Genetic Engineering Applications:
Biopharmaceuticals
Agriculture
Medical diagnosis
Pharmacogenomics/Rational drug design
Gene therapy
Ethics of Genetic Engineering
Biopharmaceuticals:
Use of recombinant DNA technology for therapeutic proteins.
Biofactories utilizing transgenic animals for therapeutics due to limitations of bacteria in producing certain human proteins.
Insulin Production:
The first biopharmaceutical, human insulin produced in E. coli, approved in 1982 by the FDA.
Process involves:
Treating cyanogen bromide to cleave insulin chains.
Transforming E. coli to produce functional insulin.
Various Gene Products and Conditions Treated:
Erythropoietin: Treats anemia (E. coli, cultured mammalian cells)
Interferons: Treats multiple sclerosis and cancer
Tissue Plasminogen Activator (tPA): Treats heart attack and stroke
Human Growth Hormone: Treats dwarfism
Monoclonal Antibodies: Against cancers
Recombinant Human Antithrombin: Treats hereditary deficiency
Edible Vaccines: Against Hepatitis B infections in transgenic bananas and yeast.
Applications in Crop Improvement:
Enhancing growth characteristics and nutritional value.
Resistance to pests, drought, and herbicides.
Roundup Ready Crops:
Glyphosate inhibits EPSP synthase; transgenic crops possess a resistant version isolated from E. coli.
Transgenic Animals:
Cows engineered to:
Increase milk nutritional value and quantity.
Protect against disease pathogens, including bioweapons.
GloFish:
Used as a bioassay for water contamination.
Transgenic Mice: Utilized for various research applications.
Cloning of genomic cassettes in E. coli, complete genome assembly in yeast, and genome transplantation to other bacteria.
Amniocentesis Process:
Analysis of amniotic fluid for genetic testing, including karyotyping and biochemical analysis.
Types of Genetic Tests:
Prenatal, newborn screening (e.g., PKU), diagnostic testing (e.g., sickle cell anemia), and predictive testing (e.g., BRCA1).
Sickle Cell Anemia Testing:
Uses RFLP (Restriction Fragment Length Polymorphism) and ASO (Allele-specific oligonucleotides).
Gene Expression Patterns:
Identification of cancer types and pathogens such as E. coli and SARS.
Identification of disease-related marker sequences through sequence analysis.
Using genomic data to tailor pharmaceutical treatments based on an individual’s genotype.
Transfer of normal genes to correct genetic defects (e.g., ADA gene therapy for SCID).
Ashanti DeSilva: First gene therapy recipient, leading a normal life post-treatment, still requiring maintenance therapy.
Previous setbacks due to immune responses and cancer risk.
Ongoing research focuses on safe gene delivery methods and effective gene expression control.
Frankenfoods:
Addressing consumer safety and environmental impact.
Performance Enhancement:
Issues with EPO and growth hormone use in sports.
Designer Babies:
Ethical lines between correction and enhancement.
Genetic Discrimination:
Impact on healthcare and employment.
Genetic testing raises ethical dilemmas, direct-to-consumer genetic testing, and handling of DNA patents, as seen in Myriad Genetics case.